In-stent repeated thrombosis secondary to coronary artery aneurysms percutaneous coronary intervention in Behchet's

Minglian Gong1,2, Yi Mao3, Jinghua Liu2

  • 1Department of Cardiology Dalian The Fifth People's Hospital Liaoning China.

Insights

Coronary artery aneurysms are a rare Behcet's disease complication. Percutaneous treatments often fail, necessitating long-term follow-up and anticoagulation to prevent thrombosis.

Area of Science:

  • Cardiology
  • Rheumatology
  • Vascular Medicine

Background:

  • Behcet's disease (BD) is a rare systemic vasculitis.
  • Coronary artery aneurysm (CAA) is an uncommon but severe manifestation of BD.
  • Acute coronary syndrome (ACS) in BD patients presents unique challenges.

Observation:

  • Percutaneous treatment strategies for CAA in BD have shown limited success in ameliorating ACS.
  • The long-term prognosis and risks associated with percutaneous intervention for coronary involvement in BD remain largely unknown.

Findings:

  • Coronary artery aneurysms in Behcet's disease are associated with a poor prognosis.
  • Percutaneous interventions for CAA in BD frequently fail to resolve acute coronary syndromes.
  • Long-term follow-up is crucial due to unknown risks of disease progression post-intervention.

Implications:

  • Long-term anticoagulant and antiplatelet therapies are recommended to prevent thrombosis and embolism in BD patients with CAA.
  • Further research is needed to establish optimal management strategies for coronary involvement in Behcet's disease.
  • Understanding the long-term outcomes of percutaneous interventions is vital for guiding clinical practice.

Related Concept Videos

Aneurysm III: Interprofessional Care01:26

Aneurysm III: Interprofessional Care

Aneurysm management involves either conservative medical therapy or surgical intervention, depending on the size and symptoms of the aneurysm. Conservative management is generally reserved for smaller, asymptomatic aneurysms, while larger or symptomatic aneurysms often necessitate surgical repair.Conservative Medical TherapyFor small, asymptomatic aneurysms, particularly abdominal aortic aneurysms (AAA) less than 5.5 centimeters in diameter, conservative medical therapy is recommended. This...
82
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
93
Peripheral Artery Disease III: Interprofessional Care01:27

Peripheral Artery Disease III: Interprofessional Care

Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...
95
Pericarditis III: Medical Management01:17

Pericarditis III: Medical Management

The primary objectives of managing pericarditis are to determine the underlying cause, provide effective therapy for treatment and symptom relief, and promptly detect signs and symptoms of cardiac tamponade. The following outlines the essential aspects of medical management for pericarditis:ObjectivesDetermine the Cause: Identifying the underlying cause of pericarditis is crucial for targeted treatment. Causes include viral infections, autoimmune diseases, post-cardiac injury syndrome, and...
83
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
91
Aneurysm II: Clinical Manifestations and Diagnostic Studies01:21

Aneurysm II: Clinical Manifestations and Diagnostic Studies

Thoracic, aortic arch and abdominal aneurysms are significant vascular conditions that can present with various clinical manifestations and lead to serious complications. Understanding these manifestations and the appropriate diagnostic studies is essential for effective management and treatment.Thoracic Aortic AneurysmsThoracic aortic aneurysms often remain asymptomatic until they reach a size that impinges on adjacent structures. They typically cause deep, diffuse chest pain that radiates to...
64